Ambeed.cn

首页 / / / / Aristolochic acid A/马兜铃酸A

Aristolochic acid A/马兜铃酸A {[allProObj[0].p_purity_real_show]}

货号:A714436 同义名: 马兜铃酸 / Aristolochic acid I; TR 1736

Aristolochic acid A是一种从马兜铃科植物(Aristolochia debilis Sieb. et Zucc.)中提取的天然产物,强烈引起卵巢成熟过程中通过抑制Akt磷酸化介导的凋亡抑制的毒性损伤。

HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Aristolochic acid A/马兜铃酸A 化学结构 CAS号:313-67-7
Aristolochic acid A/马兜铃酸A 化学结构
CAS号:313-67-7
Aristolochic acid A/马兜铃酸A 3D分子结构
CAS号:313-67-7
Aristolochic acid A/马兜铃酸A 化学结构 CAS号:313-67-7
Aristolochic acid A/马兜铃酸A 3D分子结构 CAS号:313-67-7
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

Aristolochic acid A/马兜铃酸A 纯度/质量文件 产品仅供科研

货号:A714436 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025, 188, (21): 5847-5861.e11. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025, 20, 1502-1513. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >
产品名称 NF-κB 其他靶点 纯度
Ammonium pyrrolidine-1-carbodithioate 98%
QNZ ++++

NF-κB, IC50: 11 nM

99%+
Sodium 4-Aminosalicylate Dihydrate 98%
Sodium Salicylate 95%
Parthenolide p53 97% HPLC
JSH-23 +

NF-κB, IC50: 7.1 μM

98%
Phenethyl caffeate 98%
Andrographolide 98+%
Curcumin HDAC,Nrf2 98%
SC75741 +++

NF-κB, EC50: 200 nM

99%+
CBL0137 HCl ++

NF-κB, EC50: 0.47 μM

p53 99%+
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

Aristolochic acid A/马兜铃酸A 生物活性

描述 Aristolochic Acid A (Aristolochic acid I), is the main component of plant extract Aristolochic acids, which are found in various herbal plants of genus Aristolochia and Asarum, strongly induces toxic damage during ovarian maturation by inhibiting Akt phosphorylation-mediated suppression of apoptosis. Aristolochic acid A (150, 200 μM, 24 hours) inhibits the cell viabilities of kidney cells HEK293 and HK-2. Aristolochic acid A (100, 200 μM, 24 hours) causes a concentration-dependent decrease in bladder cancer-associated protein (BLCAP) mRNA levels in kidney cells (HEK 293 and HK-2), and bladder cancer cell line (HT-1376). Aristolochic acid A (100, 200 μM, 24 hours) weakens the BLCAP protein signals in a dose-dependent manner in both HEK293 and HT-1376 cells[3]. AA (Aristolochic Acid A) has been found to damage broilers' kidneys by breaking the redox balance to form oxidative stress, along with promoting apoptosis of renal cells[4]. Additionally, AAI promoted apoptosis in SSCs, which was accompanied by upregulation of caspase 3, P53 and BAX expression and downregulation of Bcl-2 expression, and suppressed autophagy, which was accompanied by upregulation of P62 expression and downregulation of ATG5 and LC3B expression, in a concentration-dependent manner. AAI (Aristolochic acid I) impaired spermatogenesis in rats, as identified by degeneration of the seminiferous epithelium, and increased apoptosis of testicular cells[5]. The mechanism of AA-I-induced hepatotoxicity was associated with oxidative-stress-mediated apoptosis and mitochondrial damage[6].

Aristolochic acid A/马兜铃酸A 细胞实验

Cell Line
Concentration Treated Time Description References
Bone marrow-derived macrophages (BMDMs) 10 mg/ml 0, 6, 12, 24, 48 hours To study the effect of AA on macrophage polarization, results showed that AA treatment significantly increased the expression of M2-related genes. Front Immunol. 2022 May 2;13:864984.
Raw264.7 cells 10 mg/ml 0, 6, 12, 24, 48 hours To study the effect of AA on macrophage polarization, results showed that AA treatment significantly increased the expression of M2-related genes. Front Immunol. 2022 May 2;13:864984.
Rat liver microsomes 10 µM 20 min Investigation of AAI O-demethylation, identifying CYP1A and CYP2C subfamily as major catalysts Int J Mol Sci. 2015 Nov 18;16(11):27561-75.
Human liver microsomes 10 µM 20 min Investigation of AAI O-demethylation, identifying CYP1A1/2 and CYP3A4 as major catalysts Int J Mol Sci. 2015 Nov 18;16(11):27561-75.
HEK293 cells 20 µM 24 hours To validate KLF15 binding sites in the CPT1A and ACAA2 promoter regions by chromatin immunoprecipitation assay. Results showed that KLF15 binding to these promoter regions was maintained even after AAI treatment. Kidney Int. 2021 Dec;100(6):1250-1267.
HK-2 cells 20 µM 24 hours To evaluate the protective effect of KLF15 overexpression on AAI-induced cell injury. Results showed that KLF15 overexpression partially rescued the loss of FAO in AAI-treated cells. Kidney Int. 2021 Dec;100(6):1250-1267.
NRK52E cells 40 µM 24 hours To investigate the ameliorative effect of LYC on AAI-induced renal fibrosis and its mechanism. The results showed that LYC intervention activated mitophagy, reduced AAI-induced mitochondrial damage, and improved renal fibrosis by inhibiting the AKT signaling pathway. Autophagy. 2024 May;20(5):1114-1133.
Human renal proximal tubular epithelial cell line (HK-2) 100 µM 24 hours Evaluate the inhibitory effect of AAI on cell proliferation and DNA damage, SFII significantly alleviated AAI-induced DNA damage and apoptosis. Acta Pharmacol Sin. 2023 Jul;44(7):1429-1441.
Human normal liver cell line (L02) 20 µM, 50 µM 24 hours, 48 hours Evaluate the inhibitory effect of AAI on cell proliferation and DNA damage, SFII significantly alleviated AAI-induced DNA damage and apoptosis. Acta Pharmacol Sin. 2023 Jul;44(7):1429-1441.
HK-2 cells 5 µM and 10 µM 4 hours To study AAI-induced mitochondrial acidification, results showed increased mitochondrial acidification with higher AAI concentrations. Mater Today Bio. 2024 Sep 11;28:101240.
Supersomes™ (recombinant CYP enzymes expressed in insect cells) 10 µM Evaluation of cytochrome b5 effect on AAI oxidation, identifying human CYP1A1 and 1A2 as major enzymes for AAI oxidation Int J Mol Sci. 2015 Nov 18;16(11):27561-75.

Aristolochic acid A/马兜铃酸A 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
Sprague-Dawley rats Hepatocellular carcinoma model Oral 0.1, 1, or 10 mg/kg 5 days a week for 6 weeks (medium-term study) or 52 weeks (long-term study) To evaluate the tumor-initiating or -promoting activity of AAI. Results showed that high-dose AAI (10 mg/kg) promoted clonal expansion but did not induce HCC. Acta Pharmacol Sin. 2021 Dec;42(12):2094-2105
C57BL/6 mice AAI-induced renal fibrosis model Oral gavage 10 mg/kg Once daily for 28 days To investigate the ameliorative effect of LYC on AAI-induced renal fibrosis and its mechanism. The results showed that LYC intervention alleviated AAI-induced renal histopathological damage, restored renal function, and improved renal fibrosis by inhibiting the TGFB signaling pathway and activating mitophagy. Autophagy. 2024 May;20(5):1114-1133.
Mice AAN model Intraperitoneal injection 10 mg/kg 1, 3, 7, 14, 28 days To study AA-induced renal fibrosis, results showed that AA treatment significantly increased renal fibrosis and macrophage M2 polarization. Front Immunol. 2022 May 2;13:864984.
C57BL/6J mice AAI-induced acute kidney injury model Intraperitoneal injection 10 mg/kg Single injection, sacrificed after 3 days To study the role of PSTPIP2 in AAI-induced acute kidney injury, it was found that conditional knock-in of Pstpip2 alleviated kidney injury and apoptosis. Elife. 2024 Feb 5;13:e89740
C57BL/6 mice AAI-induced hepatotoxicity Mice model Intraperitoneal injection 2 mg/kg Once daily for 4 weeks or 8 weeks To investigate the mechanisms of AAI-induced hepatotoxicity, results showed that AAI exposure led to body weight loss, liver injury, inflammatory cell infiltration, and increased levels of ALT and AST. Precis Clin Med. 2022 Sep 22;5(4):pbac023
C57 BL/6 mice AA-induced nephrotoxicity model Intraperitoneal injection 2 mg/kg Once a day for 4 weeks Evaluate AA-induced nephrotoxicity and metabolic disorders Int J Biol Sci. 2022 Feb 21;18(5):2003-2017
Sprague-Dawley rats Hepatocellular carcinoma model Oral 20, 50, or 100 mg/kg Single dose To evaluate the tumor-initiating or -promoting activity of AAI. Results showed that high-dose AAI (10 mg/kg) promoted clonal expansion but did not induce HCC. Acta Pharmacol Sin. 2021 Dec;42(12):2094-2105
Mice AAI-induced nephrotoxicity model Tail vein injection 200 μM Five times per week for two weeks To study AAI-induced nephrotoxicity and mitochondrial acidification, results showed AAI caused renal injury and mitochondrial acidification, which was mitigated by LC co-treatment. Mater Today Bio. 2024 Sep 11;28:101240.
C57BL/6 mice Klf15PTKO mice Intraperitoneal injection 3 mg/kg Every 3 days for 2 weeks To evaluate the effect of PT-specific KLF15 deletion on AAI-induced kidney injury. Results showed that Klf15PTKO mice exhibited more severe tubular injury and kidney function decline after AAI treatment. Kidney Int. 2021 Dec;100(6):1250-1267.
C57BL/6 mice AAN model Intraperitoneal injection 3 mg/kg Twice a week for 4 weeks followed by 4 weeks of remodeling time To investigate whether AA induces renal aging, results showed AA caused renal atrophy, tubulointerstitial fibrosis, and renal functional decline, accompanied by increased renal p16 mRNA expression and SA-β-gal activity Int J Mol Sci. 2021 Nov 18;22(22):12432
Mice Trp53(+/+), Trp53(+/-), and Trp53(-/-) mice Intraperitoneal injection 3.5 mg/kg Daily for six days To investigate the impact of p53 on AAI-induced gene expression in vivo, results showed that AAI significantly altered gene expression in kidneys of Trp53(+/+), Trp53(+/-), and Trp53(-/-) mice Int J Mol Sci. 2019 Dec 6;20(24):6155
C57BL/6 mice Acute renal injury model and renal fibrosis model Intraperitoneal injection 5 mg/kg, 10 mg/kg Three consecutive days or 14 days after a single dose Evaluate the protective effect of SFII on AAI-induced renal injury and fibrosis, SFII effectively attenuated acute renal injury and fibrosis caused by AAI in vivo. Acta Pharmacol Sin. 2023 Jul;44(7):1429-1441.

Aristolochic acid A/马兜铃酸A 动物研究

Animal study 肾毒性[5]
动物: BALB/c 小鼠,~20 g。
给药:10 mg/kg/天,腹腔注射,3-5天。

Aristolochic acid A/马兜铃酸A 临床研究

NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT03066921 End Stage Renal Disease Not Applicable Completed - Taiwan ... 展开 >> Tungs' Taichung MetroHarbour Hospital Taichung, Taiwan 收起 <<
NCT01503645 - Unknown - Taiwan ... 展开 >> Far Estern Memorial Hospital Not yet recruiting Pan-Chiao, Taipei, Taiwan, 22060 National Taiwan University Hospital Recruiting Taipei, Taiwan, 10051 Contact: Kwan-Dun Wu, MD, PhD    +886-2-23123456 ext 5014    kdw@ntumc.org    Principal Investigator: Fe-Lin L Wu, Ph.D. 收起 <<
NCT00867633 - Unknown March 2012 Taiwan ... 展开 >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Yeong-Shiau Pu, Ph.D.    886-2-23123456 ext 65249    yspu@ntu.edu.tw 收起 <<

Aristolochic acid A/马兜铃酸A 参考文献

[1]Kwak DH, Park JH, et al. Aristolochic Acid I induces ovarian toxicity by inhibition of akt phosphorylation. Chem Res Toxicol. 2014 Dec 15;27(12):2128-35.

[2]Pan JH, Yan GJ, Song J. [The determination of aristolochic acid A in different processed Aristolochia manshuriensis and the test of influence about renal function in rats] . Zhong Yao Cai. 2010 Aug;33(8):1228-33. Chinese.

[3]Huang YT, Wu TS, Lu CC, Yu FY, Liu BH. Aristolochic acid I interferes with the expression of BLCAP tumor suppressor gene in human cells. Toxicol Lett. 2018 Jul;291:129-137

[4]Xu D, Ran C, Yin L, Lin J, Fu H, Peng X, Zhao X, Shu G. Acute and Subchronic Toxicity Studies of Aristolochic Acid A in Tianfu Broilers. Animals (Basel). 2021 May 27;11(6):1556

[5]Liu Y, He X, Wang Y, Zhou H, Zhang Y, Ma J, Wang Z, Yang F, Lu H, Yang Y, Deng Z, Qi X, Gong L, Ren J. Aristolochic acid I induces impairment in spermatogonial stem cell in rodents. Toxicol Res (Camb). 2021 Apr 26;10(3):436-445

[6]Xu D, Yin L, Lin J, Fu H, Peng X, Chang L, Zheng Y, Zhao X, Shu G. Aristolochic Acid I-Induced Hepatotoxicity in Tianfu Broilers Is Associated with Oxidative-Stress-Mediated Apoptosis and Mitochondrial Damage. Animals (Basel). 2021 Dec 2;11(12):3437

[7]Zeng Y, Li S, Wu J, Chen W, Sun H, Peng W, Yu X, Yang X. Autophagy inhibitors promoted aristolochic acid I induced renal tubular epithelial cell apoptosis via mitochondrial pathway but alleviated nonapoptotic cell death in mouse acute aritolochic acid nephropathy model. Apoptosis. 2014 Aug;19(8):1215-24.

Aristolochic acid A/马兜铃酸A 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.93mL

0.59mL

0.29mL

14.65mL

2.93mL

1.47mL

29.30mL

5.86mL

2.93mL

Aristolochic acid A/马兜铃酸A 技术信息

CAS号313-67-7
分子式C17H11NO7
分子量 341.27
SMILES Code O=C(C1=CC(OCO2)=C2C3=C4C=CC=C(OC)C4=CC([N+]([O-])=O)=C13)O
MDL No. MFCD00004996
别名 马兜铃酸 ;Aristolochic acid I; TR 1736; AristA; Birthwort; Tardolyt; NSC 50413; NSC 11926; Aristolochic Acid; Aristolochine; Aristolochin
运输蓝冰
InChI Key BBFQZRXNYIEMAW-UHFFFAOYSA-N
Pubchem ID 2236
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Inert atmosphere, 2-8°C

溶解方案

DMSO: 16 mg/mL(46.88 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。